All content for KDIGO Conversations in Nephrology is the property of KDIGO Communications and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
KDIGO Conversations in Nephrology features global experts covering a wide range of topics for clinicians treating patients with kidney disease.
Episode 11: Recent Progress in the Treatment of AAV and its Impact on the Outcome of the Patients
KDIGO Conversations in Nephrology
15 minutes
2 years ago
Episode 11: Recent Progress in the Treatment of AAV and its Impact on the Outcome of the Patients
In this episode, host Dr. Vladimir Tesar (General University Hospital, Prague) and Dr. David Jayne (Addenbrooke's Hospital, United Kingdom) discuss the roles of various agents in the induction and maintenance treatment of ANCA- associated vasculitis. They will explore the use of rituximab and complement inhibition in treating ANCA-associated vasculitis. This episode will address the gaps in knowledge and ongoing research in the field of ANCA-associated vasculitis.
This episode is supported by Amgen.
KDIGO Conversations in Nephrology
KDIGO Conversations in Nephrology features global experts covering a wide range of topics for clinicians treating patients with kidney disease.
